BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Glaucoma Foundation - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Glaucoma Foundation
X-ORIGINAL-URL:https://glaucomafoundation.org
X-WR-CALDESC:Events for The Glaucoma Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220222
DTEND;VALUE=DATE:20220223
DTSTAMP:20260406T123314
CREATED:20241002T192658Z
LAST-MODIFIED:20241121T162915Z
UID:10067-1645488000-1645574399@glaucomafoundation.org
SUMMARY:Webinar - What do cold hands have to do with glaucoma?
DESCRIPTION:Learn about Flammer’s Syndrome with Josef Flammer\, MD and patient Hillary Golden \nIn 2020\, Hillary Golden went to see an optometrist to treat a stye. She was completely surprised when the doctor was more concerned about her optic nerve. She was diagnosed with normal tension glaucoma (NTG). Hillary had lost a good amount of visual field already and was immediately referred to a glaucoma specialist.  While researching NTG\, she kept coming across something called Flammer Syndrome. She fit the patient profile\, so she read study after study to learn more.  This led her to reach out to Dr. Josef Flammer\, whom the syndrome was monikered after\, to gather more information.  She sent an email\, not expecting a reply\, and was delighted when she heard back from Dr. Flammer himself. \nHillary speaks publicly about her diagnosis\, how glaucoma affects patients in everyday life\, and how she manages her disease. Her career has included sales and training of medical devices\, imaging equipment\, and computer guided surgical navigation. She is currently a clinical consultant in the glaucoma space. \nDr. Josef Flammer is a Swiss ophthalmologist with a specialty in glaucoma. He is an emeritus director of the Eye Clinic at Basel University Hospital. Dr. Flammer was one of the first researchers to demonstrate systemic side effects of locally administered beta-blockers (i.e. eye drops) in ophthalmology. He and his collaborators found that intraocular pressure variation is as important for the development of glaucoma as a constantly elevated intraocular pressure – long considered the main\, if not the only\, cause of glaucoma. In numerous research projects\, he demonstrated that glaucoma could be caused by a dysregulation of ocular blood flow\, even at normal levels of intraocular pressure. Flammer discovered that vasospasms in the eye are a manifestation of a general vasospastic syndrome. Later\, he noted that such spasms are only the tip of the iceberg and an indication of a much more generalized vascular dysregulation in the human body\, increasing the risk of eye disease\, particularly of normal tension glaucoma. Dr. Flammer noted that people with primary vascular dysregulation have other symptoms and signs\, leading to the establishment of the term Flammer Syndrome. Among many other discoveries\, he also demonstrated the relationship between eye disease and heart disease.At the Basel Eye Clinic\, Dr. Flammer initiated one of the most renowned annual conferences for ophthalmologists in Europe\, the Basel Ophthalmo Meeting. In addition to hundreds of original papers\, he is the author of  “Glaucoma\,” a book intended for the general public which has so far been published in 22 languages. It is considered the world’s most widely used non-fiction book on this ocular disease.
URL:https://glaucomafoundation.org/event/what-do-cold-hands-have-to-do-with-glaucoma/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/what-do-cold-hands-have-to-do-wi.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211111T170000
DTEND;TZID=America/New_York:20211111T180000
DTSTAMP:20260406T123314
CREATED:20241002T194030Z
LAST-MODIFIED:20241121T163023Z
UID:10086-1636650000-1636653600@glaucomafoundation.org
SUMMARY:Webinar - NEW HORIZONS IN GLAUCOMA TREATMENT
DESCRIPTION:Dr. Jeffrey Liebmann joined us on Zoom to talk about the latest news in glaucoma procedures and treatments and answer viewer questions. This webinar was sponsored by Santen Pharmaceuticals. \n\n\n\n\n\n\n\n\n\nDr. Jeffrey M. Liebmann graduated from Boston University School of Medicine\, completed his ophthalmology residency at the State University of New York/Downstate Medical Center\, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor\, Vice-Chair\, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology\, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann serves as a member of the Board of Governors of the World Glaucoma Association\, Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. Dr. Liebmann is a past-President of the World Glaucoma Association\, American Glaucoma Society\, and the New York Society for Clinical Ophthalmology\, Emeritus Editor-in Chief of Journal of Glaucoma and was co-founder of the New York Glaucoma Research Institute\, the American Glaucoma Society Foundation and ASCRS Glaucoma Day. \nIn addition to maintaining a busy tertiary-care referral practice in New York City\, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers\, book chapters\, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma\, glaucoma progression\, glaucoma surgery\, ocular imaging\, and neuroprotection.
URL:https://glaucomafoundation.org/event/new-horizons-in-glaucoma-treatment/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/new-horizons-in-glaucoma-treatme-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210813
DTEND;VALUE=DATE:20210814
DTSTAMP:20260406T123314
CREATED:20241002T194151Z
LAST-MODIFIED:20241121T163037Z
UID:10087-1628812800-1628899199@glaucomafoundation.org
SUMMARY:A Fireside Chat With Dr. George Spaeth & Mark Lesselroth
DESCRIPTION:The Glaucoma Foundation invites you to a fireside video chat with Mark Lesselroth and Dr. George Spaeth who delve into some of the common misconceptions about glaucoma and how patients can take control of their health. \nWe will be following up on this conversation with a written Q&A in the September issue of our e- newsletter. \nWe hope you find this discussion informative and thought-provoking. If you have a comment or question\, please send it to us by email by August 30. We look forward to hearing from you.
URL:https://glaucomafoundation.org/event/a-fireside-chat-with-dr-george-spaeth-mark-lesselroth/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/fireside-chat.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210527
DTEND;VALUE=DATE:20210528
DTSTAMP:20260406T123314
CREATED:20241002T194253Z
LAST-MODIFIED:20241121T163100Z
UID:10089-1622073600-1622159999@glaucomafoundation.org
SUMMARY:Webinar - Low-Tech : High Tech Low Vision Solutions 101
DESCRIPTION:We had a panel of low-vision specialists and patient advocates talk about a range of techniques and assets you can use to improve your home and work-life. From simple low-tech methods and products to advanced optical and electronic technologies.
URL:https://glaucomafoundation.org/event/low-tech-high-tech-low-vision-solutions-101/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/08/low-tech-high-tech-low-vision-so-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210312
DTEND;VALUE=DATE:20210313
DTSTAMP:20260406T123314
CREATED:20241002T194440Z
LAST-MODIFIED:20241114T171901Z
UID:10092-1615507200-1615593599@glaucomafoundation.org
SUMMARY:Webinar - Update on Home Tonometry: An Easy Way to Track Your IOP
DESCRIPTION:Click the video below to see our webinar about “MyEYES.” MyEYES is dedicated to helping you better manage your glaucoma with access to the personal tonometer\, iCare HOME. \niCare HOME is the most advanced device available for a patient to measure their intra-ocular pressure (IOP) any time of day or night. Whether you suffer from mild or severe glaucoma or are only a glaucoma suspect\, MyEYES can help you learn more about the variability of your IOP in the convenience of your home. Managing IOP is a critical step in avoiding preventable deterioration of your vision and the iCare HOME is the next step in managing your eye health.
URL:https://glaucomafoundation.org/event/update-on-home-tonometry-an-easy-way-to-track-your-iop/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/update-on-home-tonometry-an-easy.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210227T170000
DTEND;TZID=America/New_York:20210227T180000
DTSTAMP:20260406T123314
CREATED:20241002T194350Z
LAST-MODIFIED:20241121T163138Z
UID:10090-1614445200-1614448800@glaucomafoundation.org
SUMMARY:Webinar - Bringing the Latest Glaucoma Science Directly to the Patient
DESCRIPTION:TGF held a webinar with four brief\, illuminating talks by experts on gene therapy\, optic nerve regeneration\, the role of artificial intelligence\, and the importance of trust between physician and patient. We also had perspectives from two patients. Presented in two parts with Q&As. The webinar was made possible with support from Santen\, Inc. and New York Community Trust.
URL:https://glaucomafoundation.org/event/bringing-the-latest-glaucoma-science-directly-to-the-patient/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/bringing-the-latest-glaucoma-sci.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201209
DTEND;VALUE=DATE:20201210
DTSTAMP:20260406T123314
CREATED:20241002T194537Z
LAST-MODIFIED:20241121T163227Z
UID:10093-1607472000-1607558399@glaucomafoundation.org
SUMMARY:Webinar - An Overview of Low Vision Rehabilitation with Delaram Shirazian\, OD
DESCRIPTION:Click below to see our webinar with Dr. Delaram Shirazian about low vision rehabilitation. We discuss low vision rehabilitation\, what to expect during a low vision exam\, how it differs from a regular eye exam\, low vision devices and updates in technology. \nDr. Delaram Shirazian earned her Doctor of Optometry degree from the University of Missouri – St. Louis and went on to complete a residency in Ocular Disease and Low Vision Rehabilitation at the Kansas City VA Medical Center. \nDr. Shirazian is currently an Assistant Clinical Professor at SUNY College of Optometry\, working with patients and students in primary care and low vision rehabilitation clinics. She also teaches the patient-doctor communication portion of the first-year curriculum and is the instructor of record of the Low Vision/Ocular Disease Micro-Credential program. Dr. Shirazian is a fellow of the American Academy of Optometry. \n\n\n\n\n\n\n\n\n\nYou can find additional low vision resources in our Patient Resource Center.
URL:https://glaucomafoundation.org/event/an-overview-of-low-vision-rehabilitation-with-delaram-shirazian-od/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/an-overview-of-low-vision-rehabi.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201015
DTEND;VALUE=DATE:20201016
DTSTAMP:20260406T123314
CREATED:20241002T194618Z
LAST-MODIFIED:20241121T163415Z
UID:10095-1602720000-1602806399@glaucomafoundation.org
SUMMARY:"Going Blind" Movie Panel Discussion
DESCRIPTION:Click below to view a Q&A panel with our President & CEO Elena Sturman\, activist and documentary filmmaker Joe Lovett (Director & Producer of “Going Blind”)\,  Jessica Jones (Art Teacher\, The Lavelle School for the Blind)\,  Joel Schuman\, MD\, FACS (Professor and Chairman of Ophthalmology\, NYU Langone Health)\,  Delaram Shirazian\, OD (Assistant Clinical Professor\, SUNY College of Optometry) and Nitza Daneli (Artist & Director of The Alfano Family Arts in Medicine Studio). View the website for the documentary film Going Blind.
URL:https://glaucomafoundation.org/event/going-blind-movie-panel-discussion/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/08/going-blind-movie-panel-discussi-1.jpg
END:VEVENT
END:VCALENDAR